Le Lézard
Classified in: Mining industry, Science and technology, Business
Subjects: CON, PSF

MSA Safety awarded $33 Million Breathing Apparatus Contract with U.S. Coast Guard


PITTSBURGH, Nov. 14, 2024 /PRNewswire/ -- MSA Safety, Inc. (NYSE: MSA) today announced it has been awarded a multi-year $33 million contract with the U.S. Coast Guard to provide new firefighter respiratory protective equipment. The 10-year contract covers the supply of MSA's G1 Self-Contained Breathing Apparatus (SCBA) to the operational surface fleet and surface support facilities. Initial orders under the contract, valued at approximately $22 million, were received in the third quarter of 2024.

"We are incredibly proud the U.S. Coast Guard has placed their trust and confidence in the MSA brand," said Steve Blanco, MSA Safety President and Chief Executive Officer. "The innovative design and versatility of the G1 SCBA platform helps to improve firefighter health and safety by enabling the addition of new technologies as those technologies become available. We very much look forward to this partnership and the privilege of helping to protect the members of the U.S. Coast Guard."

With more than 15 patents, the G1 SCBA includes a broad range of innovative features to enhance firefighter safety, comfort, situational awareness, and operational efficiency. These include:

Production of the new U.S. Coast Guard breathing apparatus units is underway at the company's Murrysville, Pennsylvania, manufacturing facility.  

About MSA Safety
MSA Safety Incorporated (NYSE: MSA) is the global leader in advanced safety products, technologies and solutions. Driven by its singular mission of safety, the company has been at the forefront of safety innovation since 1914, protecting workers and facility infrastructure around the world across a broad range of diverse end markets while creating sustainable value for shareholders. With 2023 revenues of $1.8 billion, MSA Safety is headquartered in Cranberry Township, Pennsylvania and employs a team of over 5,000 associates across its more than 40 international locations. For more information, please visit www.MSASafety.com.

SOURCE MSA Safety


These press releases may also interest you

at 12:55
Vertex Pharmaceuticals Incorporated today announced longer-term data for CASGEVYtm (exagamglogene autotemcel) from global clinical trials in people with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). CASGEVY is the...

at 12:35
Kite, a Gilead Company , today announced findings from three new analyses for Yescarta® (axicabtagene ciloleucel) that demonstrate improved outcomes for people living with relapsed or refractory (R/R) large B-cell lymphoma (LBCL), which were...

at 12:35
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today data from a five-year follow-up of the pivotal Phase III POLARIX study evaluating Polivy® (polatuzumab vedotin-piiq) in combination with Rituxan® (rituximab),...

at 12:35
bluebird bio, Inc. today announced new and updated data from LYFGENIAtm (lovotobegligene autotemcel, or lovo-cel) gene therapy for patients with sickle cell disease who have a history of vaso-occlusive events (VOEs). The data will be presented at...

at 12:05
ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced positive...

at 12:05
This weekend, a class action lawsuit was filed against Apple on behalf of thousands of survivors of child sexual abuse for knowingly allowing the storage of images and videos documenting their abuse on iCloud and the company's defectively designed...



News published on and distributed by: